Harold A. Kaminetzky, MD, Director, Practice Activities American College of Obstetricians and Gynecologists Washington, District of Columbia Gerald Klerman, MD (deceased) Association for Clinical Don R. Lipsitt, MD President, American Association of General Hospital Psychiatrists Russ Newman, PhD, JD Deputy Executive Director for Professional Practice American Psychological Association Pharmaceutical Manufacturers Health Outcomes Work Group Harold Alan Pincus, MD American Psychiatric Association John B. Reichman, MD Pocatello, Idaho Lorraine Richter, BS Joseph A. Rogers Mental Health Association of Peter M. Silberfarb, MD Lebanon, New Hampshire Department of Family Medicine Robert L. Thomas National Association of Organizations and Individuals Providing Additional Scientific, Technical, and Administrative Support University of Texas Southwestern Medical Center, Dallas, Texas M. Trivedi, MD, Scientific Assistant to the Chair W. Hendrickse, MD, MRCP D. Savage Agency for Health Care K. McCormick, PhD, RN, C. Crofton, PhD G. Hernandez, RN V. Montgomery K. Pearson, RPh, MPH L. Williams Editorial Associates, Fast Word, Dallas, Texas MedStat Systems, Inc., M. Madison, MPA, and staff National Institute of Mental A. Leshner, PhD G. Norquist, MD, MSPH University of Pittsburgh Washington Consulting Group, C.L. Smith Index A Acronyms, 99 Acute treatment, 101 Adequate treatment analysis, 101 clinical course and outcome of, 54 features of dysthymic disorder in, 3 Alcoholism. See also Substance abuse Alzheimer's disease, 40, 59 Amphetamines, 4, 37 Amphotericin B, 71 Anabolic steroids, 6, 69 Angiotensin I converting enzyme Anorexia, 49 Anti-infective agents, 67 Anti-inflammatory medications, 67 Antiarrhythmics, 71 Antibiotics, 71 Anticancer agents, 67 depressive effects of, 70 to treat secondary bipolar disorders, Antidepressants. See also Tricyclic manic or hypomanic episodes precipitated by, 37 in patients with genetic disposition to to treat eating disorders, 49-50 to treat psychotic depression, 28 Antihypertensives, 11, 68-69 characteristics of, 29 chronic fatigue symptoms and, 64 B Bech-Rafaelsen Depression Scale, 77 Beta-adrenergic blocking agents, 68 genetic vulnerability for, 73-74 in DSM-III-R, 38 Bipolar disorders. See also Bipolar disorder; Cyclothymic disorder clinical features and course of, 4, 21, 35-37 diagnosis of, 11, 20-21 epidemiology of, 37 explanation of, 2, 17, 101 subtypes of, 2, 19, 37-38 use of verapamil to treat, 69 description of, 2, 19 features of, 4, 36, 37 morbidity and mortality associated Bipolar II disorder description of, 19 diagnosis of, 31 features of, 37 seasonal patterns in, 37 Blood level measurements, 83 Bulimia, 49, 50 C Calcium-channel blockers, 69 Cancer, 6, 56, 62-64 Carbamazepine, 70 Cardiovascular medications, 67 Center for Epidemiological Studies- Children dysthymic disorder in, 3, 33 depression in patients with, 58-59 coexisting with medical conditions, description of, 1, 12 differential diagnosis of, 7-8, 19-20, in geriatric patients, 4, 40, 41 patient self-report questionnaires to prevalence of, 1, 3-4, 10, 23-25 risk factors for, 1, 3, 5-7, 23, 73 social stigma associated with, 9, Depression Guideline Panel, 10, 12 interpretation of scientific literature literature reviews and guideline development in, 12-15 overview of, 9-10 Depression not otherwise specified clinical features and course of, 33-34, cost of untreated, 34-35 Dexamethasone suppression test, 79, 81 Diagnostic and Statistical Manual of Mental Disorders, Third Edition, bereavement in, 53, 54 bipolar disorder not otherwise definition of depression in, 1, 12 major depressive disorder in, 18 clinical reassessment as critical Drug abuse, 46. See also Substance Dysthymic disorder clinical features and course of, 3, costs of untreated, 33 |